Learn More
Medchemexpress LLC Seralutinib | 1619931-27-9 | 99.94% | 469.53 | 100 MG

Supplier: Medchemexpress LLC HY10919010MM/1ML
Seralutinib (GB002) is an inhaled PDGFRα and PDGFRβ inhibitor. It also targets CSF1R and c-KIT with IC50s of 8 nM and 14 nM, respectively. This product is used in the study for pulmonary arterial hypertension.
- Inhaled PDGFRα and PDGFRβ inhibitor
- Targets CSF1R and c-KIT
- Used in the study for pulmonary arterial hypertension
- Significantly reduces right ventricular systolic pressure and mean pulmonary artery pressure
- Reduces pulmonary arteriole muscularization
- Restores BMPR2 protein expression in the lung lobes
- Well tolerated
- Appearance: Solid, white to light yellow
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.